Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique

References

• Drug Monograph. Methotrexate. Cancer Care Ontario [online] 2011. Available at: https://www.cancercare.on.ca/CCO_DrugFormulary/Pages/DfPdfContent.aspx?itemId=94031. Accessed on 9 May 2011.
   Google Scholar
• Bonetti A, Chatelut E, Kim S. (1994). An extended-release formulation of methothrexate for subcutaneous administration. Cancer Chemother Pharmacol, 33:303–306.
   PubMed Web of Science ®Google Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. (2004). Deformable liposomes for dermal administration of methotrexate. Int J Pharm, 270:119–125.
   PubMed Web of Science ®Google Scholar
• Bethesda MD. Methotrexate. American Society of Health-System Pharmacists, Inc. Toxnet [online] 2005: p. 1110. Available at: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/a?dbs+hsdb:@term+@DOCNO+3123. Accessed 14 November 2010.
   Google Scholar
• Material Safety Data Sheet. Methotrexate USP.MSDS. Creation Date: 14 June 2000.
   Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Ashnagar A, Naseri NG, Khanaki B. (2007). Study of the β-cyclodextrin imipramine hydrochloride inclusion complex and determination of its stability constant (K) by UV-visible spectroscopy. E-J Chem, 4:550–558.
   Google Scholar
• Helena H. (2006). Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications. England: Wiley-VCH, 19:344–362.
   Google Scholar
• Stojanov M, Larsen KL. (2012). Cetirizine release from cyclodextrin formulated compressed chewing gum. Drug Dev Ind Pharm, 38:1061–1067.
   PubMed Web of Science ®Google Scholar
• Tang J. (2007). Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs. Curr Drug Ther, 2:85–93.
   Google Scholar
• Constantinides PP, Scalart J. (1997). Formulation and physical characterization of water-in-oil microemulsion containing long-versus medium-chain glycerides. Int J Pharm, 158:57–68.
   Web of Science ®Google Scholar
• Bandivadeka MM, Pancholi SS, Kaul-Ghanekar R, Choudhari A, Koppikar S. (2012). Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug. Drug Dev Ind Pharm, 38:883–892.
   PubMed Web of Science ®Google Scholar
• Dalmora ME, Dalmora SL, Oliveira AG. (2001). Inclusion complex of piroxicam with beta-cyclodextrin and incorporation in cationic microemulsion. In vitro drug release and in vivo topical anti-inflammatory effect. Int J Pharm, 222:45–55.
   PubMed Web of Science ®Google Scholar
• Tonnesen HH. (2003). The Photostability of Drugs and Drug Formulations. U.K & U.S.A: The Taylor & Francis e-Library, 305–321.
   Google Scholar
• Wu W, Wang Y, Que L. (2006). Enhanced bioavailability of silymarin by self microemulsifying drug delivery system. Eur J Pharm Biopharm, 63:288–294.
   PubMed Web of Science ®Google Scholar
• Patel AR, Vavia PR. (2007). Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. The AAPS Journal, 9(3):Article 41.
   Google Scholar
• Marques HMC, Hadgraft J, Kellaway IW. (1990). Studies of cyclodextrin inclusion complexes I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int J Pharm, 63:259–266.
   Web of Science ®Google Scholar
• Pokharkar V, Khanna A, Venkatpurwar V, Dhar S, Mandpe L. (2009). Ternary complexation of carvediol, β-cyclodextrin and citric acid for mouth-dissolving tablet formulation. Acta Pharm, 59:121–132.
   PubMed Web of Science ®Google Scholar
• Singh R, Bharti N, Madan J, Hiremath SN. (2010). Characterization of cyclodextrin inclusion complexes – a review. J Pharm Sci Tech, 2(3):171–183.
   Google Scholar
• Chowdhary KPR, Madhusudhan P. (1990). Studies on preparation and evaluation of solvent deposited systems of piroxicam. Indian J Pharm Sci, 52:32–33.
   Google Scholar
• Xiang TX, Anderson BD. (1990). Inclusion complexes of purine nucleosides with cyclodextrins: II. Investigation of inclusion complex geometry and cavity microenvironment. Int J Pharm, 59(1):45–55.
   Google Scholar
• Otero-Esppinar FJ, Igea AN, Gonzalez NG, Jato VJL, Mendez JB. (1992). Interaction of Naproxen with β-cyclodextrin in solution and in the solid state. Int J Pharm, 79(2):149–157.
   Google Scholar
• Linjie L, Xiujuan P, Wei Z, Siling W. (2007). Formulation design and in vitro evaluation of silymarin-loaded self-microemulsifying drug delivery systems. Asian J Pharm Sci, 2(4):150–160.
   Google Scholar
• Mistry RB, Sheth NS. (2011). A review: self emulsifting drug delivery system. Int J Pharm & Pharm Sci, 3(Suppl 2).
   Google Scholar
• Gursoy RN, Benita G. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother, 58:173–182.
   PubMed Web of Science ®Google Scholar
• Tarr BD, Yalkowsky SH. (1989). Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size. Pharm Res, 6:40–43.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benita S. (1996). Positively-charged self-emulsifying oil formulation for improving oral bioavalability of progesterone. Pharm Dev Technol, 1:147–157.
   PubMedGoogle Scholar
• Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm, 371:148–155.
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, Xu J. (2008). Preparation and evaluation of selfmicroemulsifying drug delivery system of oridonin. Int J Pharm, 355:269–276.
   PubMed Web of Science ®Google Scholar
• Elnaggar YSR, El-Massik MA, Abdallah OY. (2009). Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm, 380:133–141.
   PubMed Web of Science ®Google Scholar
• Szejtli J. (1994). Medicinal applications of cyclodextrins. Med Res Rev, 14:353–386.
   PubMed Web of Science ®Google Scholar